IT1254147B - Metodo di rivelazione di marcatori tumorali. - Google Patents

Metodo di rivelazione di marcatori tumorali.

Info

Publication number
IT1254147B
IT1254147B ITRM920093A ITRM920093A IT1254147B IT 1254147 B IT1254147 B IT 1254147B IT RM920093 A ITRM920093 A IT RM920093A IT RM920093 A ITRM920093 A IT RM920093A IT 1254147 B IT1254147 B IT 1254147B
Authority
IT
Italy
Prior art keywords
detection
cancer markers
antigens
interferon
stimulation
Prior art date
Application number
ITRM920093A
Other languages
English (en)
Inventor
Stefano Iacobelli
Original Assignee
Uni Degli Studi G D Annunzio C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi G D Annunzio C filed Critical Uni Degli Studi G D Annunzio C
Priority to ITRM920093A priority Critical patent/IT1254147B/it
Publication of ITRM920093A0 publication Critical patent/ITRM920093A0/it
Priority to PCT/IT1993/000011 priority patent/WO1993016389A1/en
Priority to AU36478/93A priority patent/AU3647893A/en
Publication of ITRM920093A1 publication Critical patent/ITRM920093A1/it
Application granted granted Critical
Publication of IT1254147B publication Critical patent/IT1254147B/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

E' descritto un metodo di rivelazione in vitro di antigeni tumorali, in particolare l'antigene 90K comprendente una stimolazione dei livelli di detti antigeni con interferone.
ITRM920093A 1992-02-12 1992-02-12 Metodo di rivelazione di marcatori tumorali. IT1254147B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITRM920093A IT1254147B (it) 1992-02-12 1992-02-12 Metodo di rivelazione di marcatori tumorali.
PCT/IT1993/000011 WO1993016389A1 (en) 1992-02-12 1993-02-12 A method to detect tumoral markers
AU36478/93A AU3647893A (en) 1992-02-12 1993-02-12 A method to detect tumoral markers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920093A IT1254147B (it) 1992-02-12 1992-02-12 Metodo di rivelazione di marcatori tumorali.

Publications (3)

Publication Number Publication Date
ITRM920093A0 ITRM920093A0 (it) 1992-02-12
ITRM920093A1 ITRM920093A1 (it) 1993-08-12
IT1254147B true IT1254147B (it) 1995-09-11

Family

ID=11400678

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920093A IT1254147B (it) 1992-02-12 1992-02-12 Metodo di rivelazione di marcatori tumorali.

Country Status (3)

Country Link
AU (1) AU3647893A (it)
IT (1) IT1254147B (it)
WO (1) WO1993016389A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0747705A1 (en) * 1995-06-09 1996-12-11 Bayer Corporation Specific determination of NCA 90 glycoform in the blood of cancer patients

Also Published As

Publication number Publication date
AU3647893A (en) 1993-09-03
ITRM920093A1 (it) 1993-08-12
WO1993016389A1 (en) 1993-08-19
ITRM920093A0 (it) 1992-02-12

Similar Documents

Publication Publication Date Title
DE122010000015I1 (de) Kombinierte Impfstoffe, die Hepatitis-B-Oberflächen antigen und andere Antigene enthalten
AU2953895A (en) Multi-stage cascade boosting vaccine
TR200001253T2 (tr) Tümöre özel antijenler
EP0597829A4 (en) NEW MONOCLONAL ANTIBODY DRESSES AGAINST A NEW ANTIGEN ASSOCIATED WITH HUMAN TUMORS.
EA199700126A1 (ru) Вакцина против гепатита в
GB2185266B (en) Monoclonal antibodies cross-reactive and cross-protective against p. aeruginosa serotypes
NO902696D0 (no) Ny familie av modifiserte hoeyaffinitetsantistoff for kreftbehandling.
FI903228A0 (fi) Enzym-immunitetsprov foer antigen och foer detta aondamaol anvaend fast fas.
AU7198291A (en) Human monoclonal antibodies against rabies viruses, the production and the use thereof
IT8820313A0 (it) Rilevatore di prossimita'induttivo.
IT1198289B (it) Antigene di flavvirus
IT1264965B1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
DK169987D0 (da) Human tumor-associated antigen, ca-ou1
IT1254147B (it) Metodo di rivelazione di marcatori tumorali.
ITRM920100A1 (it) Sequenze genetiche per l'antigene 90k associato a tumori.
ATE109004T1 (de) Toleranzinduktion gegenüber einem fremdantigen.
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
NZ220797A (en) Male specific antibody against male specific antigen and its production
DE59710330D1 (de) Hybridzelle und deren Verwendung zur Herstellung eines Arzneimittels zur Induktion einer Tumorimmunität
ITRM910385A0 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni.
ITRM920099A1 (it) Antigene 90k associato a tumori.
ES2113765T3 (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaespiro(4.5)decano-2-propanamina.
AU6596390A (en) Monoclonal antibodies cross-reactive and cross-protective against p. aeruginosa serotypes
AU2687992A (en) Sf-25 antibodies, especially chimeric antibodies, with specificity for the human tumor sf-25 antigen, methods for their production, and uses thereof
AU6162794A (en) Carcinoma associated antigen (ng1) monoclonal antibodies against ng1, methods of producing these antibodies and use therefor